Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jan 4;16(1):e0244347. doi: 10.1371/journal.pone.0244347

Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic

Mustafa Sevinc 1, Nuri Baris Hasbal 2, Tamer Sakaci 1,*, Taner Basturk 3, Elbis Ahbap 1, Mustafa Ortaboz 1, Emrah Erkan Mazi 1, Efruz Pirdogan 4, Jonathan Ling 5, Abdulkadir Unsal 3
Editor: Jose A Muñoz-Moreno6
PMCID: PMC7781368  PMID: 33395428

Abstract

Introduction

Pneumonia of unknown cause was detected on 30 December 2019 in China. It was categorized as an outbreak and named as COVID-19 by the World Health Organization. The pandemic affects all people, but patient groups such as hemodialysis (HD) patients have been particularly affected. We do not know if refugees suffered more during the outbreak. In this study, we compared depressive symptom frequency between Syrian refugee HD patients and Turkish ones.

Methods

The study had a single-center, cross-sectional design. Demographic and clinical data were collected retrospectively from patients’ files containing details about past medical history, demographic variables and laboratory values. Validated Turkish and Arabic forms of Beck Depression Inventory (BDI) were used to assess depressive symptoms. BDI scores were compared according to nationality, demographic features and clinical data. A BDI score more than 14 was accepted as suspicion of depression.

Results

119 patients were enrolled in the study. After the exclusion of 22 patients, 75 Turkish and 22 Syrian patients were included for further analysis. The median BDI (interquartile range) score for Turkish and Syrian patients were 12 (7–23) and 19.5 (12.7–25.2), respectively (p = 0.03). Suspicion of depression was present at 42.7% of Turkish, and 72.7% of Syrian HD patients (p = 0.013). Regarding all patients, phosphorus level, Kt/V, and nationality were significantly different between patients with and without suspicion of depression (p = 0.023, 0.039, 0.013, respectively).

Conclusion

Syrian patients had higher BDI scores and more depressive symptoms than Turkish patients. Additional national measures for better integration and more mental support to Syrian HD patients are needed.

Introduction

Pneumonia of unknown cause was detected on 30 December 2019 in China. It was categorized as an outbreak and named as COVID-19 by the World Health Organization [1]. The first COVID-19 case was reported on 10 March 2020 in Turkey [2]. People older than 65 years old began their lockdown on 21 March 2020 and people younger than 20 years old started to lockdown on 03 April 2020. Total lockdown has been done a few times lasting for three or four days, especially at weekends.

Renal replacement modalities have been affected in different ways during the pandemic. Patients with kidney transplantation, performing home hemodialysis (HD) and peritoneal dialysis have been advised to isolate themselves at homes. However, center HD patients continued to attend dialysis centers.

Depression is a frequent co-morbidity at HD patients. It can be screened by a few types of self-questionnaires validated in this population such as Beck depression inventory (BDI) [3]. The frequency of depressive symptoms during pandemic on chronic HD patients is not known.

The Syrian civil war started on 11 March 2011. Turkey currently hosts 3.6 million registered Syrian refugees [4]. There are many Syrian center HD patients both in Turkey and in our unit. The number of Syrian refugees under HD therapy was 345 in 2019 [5]. We do not know if there is a difference in depressive symptom frequency between Syrian refugee HD patients and Turkish ones or not. This study aims to compare BDI scores of Turkish and Syrian maintenance HD patients during the COVID-19 pandemic.

Methods

This cross-sectional study (Clinicaltrials.gov: NCT04444557) was approved by the local ethics committee of Sisli Hamidiye Etfal Education and Research Hospital on 12 May 2020 (Ref. number 1514). All data were fully anonymized before access. Participants signed written consent forms both to participate in the study and to have data from their medical records used in research.

All HD patients in the same center were invited to participate in the study. Exclusion criteria were as follows: patients younger than 18 years old, patients undergoing home-HD, history of HD less than three months, inability to complete the questionnaire, nationalities other than Turkish and Syrian, not volunteering to fill the form, history of hospitalization due to any reason during pandemic time starting from 10 March 2020, and history of COVID-19 before questionnaire. BDI forms were filled between 17 April 2020 and 12 May 2020. Past medical records were accessed at the same day patients completed the BDI questionnaire.

Demographic data were collected retrospectively from patients’ files. These files contain the demographic details of patients filled at admission to our dialysis center and patients’ past and current laboratory values. Age, sex, nationality, marital status, education level, height, weight, etiology of kidney disease, the date for initiation of center HD, last hemoglobin, albumin, phosphorus, parathyroid hormone, Kt/v, creatinine levels and, Charlson comorbidity index were noted. Marital status was grouped as married and not married including single, divorced, and widow.

BDI consists of 21 questions and every question has four choices ranging from 0 to 3 in which 0 represents the absence of a problem, and 3 represents an extreme problem. Therefore, the total BDI score can be between 0 and 63 points. BDI score of more than 14 was accepted as suspicion of depression in patients with end-stage renal disease (ESRD) [68]. The frequencies of depressive symptoms were compared between nationalities. The validated Turkish and Arabic forms of BDI version-I were filled by patients themselves [911]. If help was required to complete the questionnaire, a native Arabic physician working at our hemodialysis center (SS) and the official Arabic translator of our institution (SA) helped Syrian patients.

BDI score was compared according to age group (<65 years or ≥65 years), sex, education level, marital status, body mass index (<25 kg/m2, 25–30 kg/m2, >30 kg/m2), presence of diabetes mellitus, presence of hypertension, HD vintage (below or above median), hemoglobin level (<10 g/dl, 10–12 g/dl, >12 g/dl), phosphorus level (<3.5 mg/dl, 3.5–5.5 mg/dl, >5.5 mg/dl), albumin level (<3.5 gr/dl or ≥3.5 gr/dl), parathyroid hormone level (below or above median), Kt/v (<1.4 or ≥1.4), and nationality. BDI score was also divided into cognitive-affective and somatic-performance subscales [12]. These were compared to nationality as well.

Statistical analysis

Statistical analyses were performed with the Scientific Package for Social Science (version 21.0; SPSS Inc., Chicago, IL, USA). Continuous variables were given as mean ± standard deviation if they were distributed normally or as median (interquartile range) if they were distributed abnormally. Qualitative variables were given as a percentage. A comparison of normally distributed data was performed by independent samples t-test. Abnormally distributed data was compared with the Mann-Whitney U test. Categorical variables were compared by the Chi-Square test. Differences were considered statistically significant for p values less than 0.05.

Results

One hundred and nineteen patients were enrolled to the study. After the exclusion of 22 patients for a range of reasons, 75 Turkish and 22 Syrian patients were included for further analysis (Fig 1). The mean age of patients was 51.6 ± 15.5 years. The most common cause of ESRD was hypertension (32%). Median HD vintage was 3.7 (1.8–7.4) years (Table 1).

Fig 1. Details of the patient cohort.

Fig 1

After enrollment of all center hemodialysis patients (n = 119), 22 patients were excluded due to following reasons: unwilling to participate (n = 4), younger than 18 years old (n = 3), inability to cooperate (n = 6), COVID-19 history (n = 5), hemodialysis history less than 3 months (n = 2), other nationalities (n = 2). Seventy-five Turkish, 22 Syrian patients’ data were analyzed further.

Table 1. Demographic characteristics, laboratory values of all patients, Turkish, and Syrian subgroups.

Parameter All patients (n = 97) Turkish (n = 75) Syrian (n = 22) p
Age, years, mean ± SD 51.6±15.5 52.1±16.1 49.9±13.2 0.568
Female patients (%) 44.3 52 18.2 0.005
Education level (%) 0.060
Illiterate 6.0 4.8 9.5
Literate 15.7 16.1 14.3
Primary school 49.4 53.2 38.1
Secondary school 13.3 14.5 9.5
High school 12 11.3 14.3
University 3.6 - 14.3
Marital status 0.007
Married (%) 56.7 49.3 81.8
BMI, kg/m2, median (IR) 21.8 (19.2–25.0) 21.9 (19.3–25.3) 21.1 (19.1–24.2) 0.435
ESRD etiology (%) 0.905
Diabetes 18.6 20 13.6
Hypertension 32 32 31.8
Glomerulonephritis 7.2 6.7 9.1
Polycystic kidney disease 7.2 8 4.5
Unknown 14.4 12 22.7
Miscellaneous 20.6 21.3 18.2
Diabetes mellitus (%) 21.6 24 13.6 0.299
Hypertension (%) 47.4 48 45.5 0.833
Hemodialysis vintage, years, median (IR) 3.7 (1.8–7.4) 4.0 (1.9–10.4) 2.7 (1.6–5.3) 0.112
Hemoglobin, (g/dl), mean ± SD 10.7±1.6 10.6±1.6 10.8±1.7 0.680
Phosphorus, (mg/dl), mean ± SD 5.5±1.5 5.3±1.5 6.0±1.5 0.085
Albumin, g/dl, median (IR) 3.7 (3.5–3.9) 3.7 (3.5–3.9) 3.8 (3.5–4.1) 0.152
Parathyroid hormone, (ng/L) median (IR) 537.5 (343.7–786.7) 548 (346.7–796.5) 484.5 (309.7–750.0) 0.420
Kt/V, mean ± SD 1.7±.0.2 1.7±0.2 1.6±0.2 0.056
Creatinine, mg/dl, median (IR) 9.1 (6.8–10.4) 9.0 (6.5–10.2) 9.4 (7.4–10.9) 0.180
Charlson comorbidity index, median (IR) 3 (2–5) 4 (2–5) 3 (2–4) 0.171

BMI: body mass index

ESRD: end-stage renal disease

IR: interquartile range

SD: standard deviation

The mean age for Turkish patients was 52.1 ± 16.1 years and 49.9 ± 13.2 years for Syrian patients (p = 0.568) (Table 1). Female patients were 52.0% of the Turkish cohort and 18.2% of the Syrian cohort (p = 0.005). The education level was similar between the two nationalities (p = 0.06). Marriage rate was 49.3% in Turkish and 81.8% in Syrian patients (p = 0.007).

The median BDI score for Turkish patients was 12 (7–23). It was 19.5 (12.7–25.2) for Syrian patients (p = 0.03) (Fig 2). The median somatic-performance subscale scores for Turkish and Syrian patients were 2 (1–5) and 3.5 (2–6.2), respectively (p = 0.02). Affective-cognitive subscale median score for Turkish patients was 9 (6–18) whereas it was 14 (10–18) for Syrian patients (p = 0.05).

Fig 2. Distribution of BDI scores for nationalities.

Fig 2

Every circle represents a Turkish, a triangle represents a Syrian patient. The median BDI score was 12 (7–23) for Turkish patients, 19.5 (12.7–25.2) for Syrian patients (p = 0.03).

Depressive symptoms were present in 49.5% of the total cohort. Patients with and without depressive symptoms were compared on multiple variables (Table 2). Phosphorus level and Kt/V were found different between two groups (p = 0.023, 0.039, respectively). Depressive symptoms were present at 42.7% of Turkish, and 72.7% of Syrian HD patients (p = 0.013).

Table 2. Demographic and laboratory characteristics of patients with and without depressive symptoms.

BDI score ≤14 BDI score >14 p
Age, years, mean ± SD 50.5±15.8 52.7±15.1 0.484
Female patients (%) 40.8 47.9 0.482
Education level (%) 0.154
Illiterate 6.8 5.1
Literate 13.6 17.9
Primary school 52.3 46.2
Secondary school 9.1 17.9
High school 18.2 5.1
University - 7.7
Marital status 53.1 60.4 0.465
Married (%)
BMI, kg/m2, median (IR) 21.6 (19.0–26.1) 21.8 (19.4–24.6) 0.907
Diabetes mellitus (%) 18.4 25.0 0. 428
Hypertension (%) 49.0 45.8 0.561
Hemodialysis vintage, years, median (IR) 3.6 (1.9–7.2) 3.9 (1.7–9.8) 0.900
Hemoglobin, (g/dl), mean ± SD 10.8±1.6 10.5±1.6 0.500
Phosphorus, (mg/dl), mean ± SD 5.9±1.5 5.1±1.5 0.023
Albumin, g/dl, median (IR) 3.8 (3.6–4.0) 3.7 (3.5–3.9) 0.394
Parathyroid hormone, (ng/L) median (IR) 518 (368–799) 546 (312–766) 0.629
Kt/V, mean ± standard deviation 1.7±0.2 1.6±0.2 0.039
Creatinine, mg/dl, median (IR) 9.3 (7.1–10.5) 8.7 (6.5–10.2) 0.194
Charlson co morbidity index, median (IR) 3 (2–5) 4 (2.2–5) 0.120
Nationality 0.013
Turkish 57.3 42.7
Syrian 27.3 72.7

BDI: Beck Depression Inventory

BMI: body mass index

ESRD: end-stage renal disease

IR: interquartile range

SD: standard deviation

Discussion

This study investigated BDI scores between Turkish and Syrian HD patients during the COVID-19 pandemic. Syrian patients had higher BDI scores than Turkish patients.

After Turkey has started to accept refugees from Syria, free healthcare facilities including hemodialysis and kidney transplantation were established [13]. For HD, Syrian and Turkish patients have equal conditions including HD schedules (three times a week, four hours), and transport facilities. Drugs are supplied free of charge to Syrian patients, like Turkish ones. The groups were similar in many respects, with laboratory features hemoglobin, phosphorus, albumin, parathyroid hormone, Kt/V in both groups not differing significantly between the Syrian and Turkish patients. In our cohort, most of the Syrian patients (81.8%) were male, although 54.0% of all Syrian refugees [14] and 51.6% of Syrian hemodialysis patients [5] in Turkey were male. There could be a male predominance by chance in our dialysis center.

Screening frequency of depressive symptoms by the BDI score without a clinical interview is an established strategy in ESRD patients [3, 7, 8]. BDI-I questionnaire was used in this study because of some advantages. It was a practical, easy, reliable and valid self-report system that has been used since 1961 [11, 15]. It could be completed by patients themselves which would minimize close and long contacts with patients during the pandemic and prevent potential COVID-19 transmission. Moreover, to the best of our knowledge, it is the only self-report screening measure that has been validated in both Turkish and Arabic languages. Besides these advantages, BDI-I form has some limitations. It has been focused more on cognitive and affective symptoms than somatic functions. Furthermore, it could be biased by organic symptoms. It was updated as BDI-II form at 1996 in response to American Psychiatric Association’s publication of DSM-IV criteria for major depressive disorder [16]. Despite this updated version, BDI-I is still widely used in different patient populations [17].

Patients with and without depressive symptoms had similar demographic and laboratory features except for phosphorus level, Kt/V, and nationality. Some similar studies found no association between depressive symptoms and phosphorus level or Kt/V although the number of participants was less than our cohort and the definition of suspicion of depression was different from each other in all studies [1821]. The difference between our study and previous studies may be due to these reasons. Furthermore, there are many additional probable reasons including adherence to diet and prescribed drugs, quality of hemodialysis, etc. These factors, unfortunately, were not in the scope of the trial design.

Frequency of depressive symptoms in HD population is reported between 0 and 100% depending on the study and assessment tool [6]. Although it is unknown during the COVID-19 pandemic in the HD population, depressive symptom frequency was found between 18.7–35.4% in population-based studies [2226]. Mazza et al have demonstrated that the risk of depressive symptoms was increased 22% more if medical problems were positive [27] which might be translated as depressive symptoms were expected more in HD population.

Mental health studies with the Syrian refugee population in Turkey out of the pandemic time were found depressive symptom frequency as 36.1%, 37.4%, and 70.5% [2830]. There is a sensitivity for the protection of both physical and mental health of refugees or immigrants during the COVID-19 pandemic [3134] although no published studies could be found.

Yilmaz et al have shown that Syrian maintenance HD patients were less compliant with their HD schedules [35]. Their per capita income was lower than Turkish patients, although their employment rate was higher. The number of Syrian household members was higher than Turkish patients but hot water accessibility was lower for the Syrian group. Similar BDI scores might be expected between Turkish and Syrian patients if the conditions were the same for both groups. However, providing equal physical and financial conditions only at peridialysis environment seemed to be insufficient for equal score expectation because we found that total BDI score, somatic-performance subscale score and affective-cognitive subscale score were all higher in Syrian patients than Turkish ones. As a result, it seems that we need to provide many other facilities to talk about equality between the two groups. These might be steps to improve language barrier between adult Syrian patients and Turkish service providers at all facilities including hospitals and other institutions. This could be with two methods: enabling Syrians to learn Turkish and maintaining more translation support at every institution or integrating native Syrian employees to these institutions like hospitals. Language support would help integration with the Turkish population. Most importantly, they should have been accepted and behaved like as others in Turkey, not as refugees. Integrating 4 million people into an economically hard stressed country in the midst of a pandemic is not easy but it seems as a necessity.

To the best of our knowledge, this is the first HD study comparing Turkish patients' and Syrian refugees' depressive symptoms. The main limitation of this study is the absence of control BDI scores of this cohort out of the pandemic period. Even though it will not change the main result that the Syrian patients have had more depressive symptoms during the COVID-19 pandemic, we cannot infer how COVID-19 affected the results exactly. Control BDI scoring was not performed because the number of cases continues to be high enough to ignore the effects of pandemic even though many precautions were reversed recently. Moreover, the exact time for the exact reversal of pandemic is not known.

Besides measures taken until now, additional national measures for better integration and more mental support for Syrian HD patients are needed.

Acknowledgments

Authors thank to Dr Alp Ikizler for his help during proofreading.

Data Availability

We have uploaded our date via Dryad system by doi:10.5061/dryad.wwpzgmshv.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Rolling updates on coronavirus disease (COVID-19) [cited 22.06.2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
  • 2.Türkiye'deki Günlük COVID-19 Vaka Sayıları [cited 22.06.2020]. Available from: https://covid19bilgi.saglik.gov.tr/tr/haberler/turkiye-deki-gunluk-covid-19-vaka-sayilari.html.
  • 3.King-Wing Ma T, Kam-Tao Li P (2016) Depression in dialysis patients. Nephrology (Carlton);21(8):639–46. 10.1111/nep.12742 [DOI] [PubMed] [Google Scholar]
  • 4.Refugees and Asylum Seekers in Turkey 2020 [cited 21.06.2020]. Available from: https://www.unhcr.org/tr/en/refugees-and-asylum-seekers-in-turkey.
  • 5.Gursu M, Arici M, Ates K, Kazancioglu R, Yavas PG, Ozturk M, et al. (2019) Hemodialysis Experience of a Large Group of Syrian Refugees in Turkey: All Patients Deserve Effective Treatment. Kidney Blood Press Res;44(1):43–51. 10.1159/000498832 [DOI] [PubMed] [Google Scholar]
  • 6.Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL (2007) Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol;2(6):1332–42. 10.2215/CJN.03951106 [DOI] [PubMed] [Google Scholar]
  • 7.Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA (2006) The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int;69(9):1662–8. 10.1038/sj.ki.5000308 [DOI] [PubMed] [Google Scholar]
  • 8.Bautovich A, Katz I, Loo CK, Harvey SB (2018) Beck Depression Inventory as a screening tool for depression in chronic haemodialysis patients. Australas Psychiatry;26(3):281–4. 10.1177/1039856218758582 [DOI] [PubMed] [Google Scholar]
  • 9.Hisli N (1989) Beck depresyon envanterinin universite ogrencileri icin gecerliligi, guvenilirligi. (A reliability and validity study of Beck Depression Inventory in a university student sample). J Psychol;7:3–13. [Google Scholar]
  • 10.Abdel-Khalek AM (1998) Internal consistency of an Arabic Adaptation of the Beck Depression Inventory in four Arab countries. Psychol Rep;82(1):264–6. 10.2466/pr0.1998.82.1.264 [DOI] [PubMed] [Google Scholar]
  • 11.BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J (1961) An Inventory for Measuring Depression. Archives of General Psychiatry;4(6):561–71. 10.1001/archpsyc.1961.01710120031004 [DOI] [PubMed] [Google Scholar]
  • 12.Dozois KSd David J. A., Ahnberg Jamie L. (1998) A Psychometric Evaluation of the Beck Depression Inventory. Psychological Assessment;10(2):83–9. [Google Scholar]
  • 13.Sevinc M, Hasbal NB, Ozcelik G, Akinci N, Basturk T, Koc Y, et al. (2019) Kidney Transplantation Outcomes in Temporarily Protected Syrian Patients With End-Stage Renal Failure in Turkey. Transplant Proc;51(7):2279–82. 10.1016/j.transproceed.2019.01.194 [DOI] [PubMed] [Google Scholar]
  • 14.TEMPORARY PROTECTION [cited 27.06.2020]. Available from: https://en.goc.gov.tr/temporary-protection27.
  • 15.Beck AT, Steer RA, Carbin MG (1988) Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review;8(1):77–100. [Google Scholar]
  • 16.Beck AT, Steer RA, Brown GK. BDI-II, Beck depression inventory: manual 1996. [Google Scholar]
  • 17.Pop-Jordanova N (2017) BDI in the Assessment of Depression in Different Medical Conditions. PRILOZI;38(1):103–11. 10.1515/prilozi-2017-0014 [DOI] [PubMed] [Google Scholar]
  • 18.Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M (2007) Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr;17(6):381–8. 10.1053/j.jrn.2007.08.008 [DOI] [PubMed] [Google Scholar]
  • 19.Koo JR, Yoon JW, Kim SG, Lee YK, Oh KH, Kim GH, et al. (2003) Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis;41(5):1037–42. 10.1016/s0272-6386(03)00201-4 [DOI] [PubMed] [Google Scholar]
  • 20.Kalender B, Ozdemir AC, Koroglu G (2006) Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract;102(3–4):c115–21. 10.1159/000089669 [DOI] [PubMed] [Google Scholar]
  • 21.Ibrahim S, El Salamony O (2008) Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol;28(5):784–91. 10.1159/000131101 [DOI] [PubMed] [Google Scholar]
  • 22.Durankus F, Aksu E (2020) Effects of the COVID-19 pandemic on anxiety and depressive symptoms in pregnant women: a preliminary study. J Matern Fetal Neonatal Med:1–7. 10.1080/14767058.2020.1763946 [DOI] [PubMed] [Google Scholar]
  • 23.Choi EPH, Hui BPH, Wan EYF (2020) Depression and Anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health;17(10). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Huang Y, Zhao N (2020) Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res;288:112954 10.1016/j.psychres.2020.112954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gonzalez-Sanguino C, Ausin B, Castellanos MA, Saiz J, Lopez-Gomez A, Ugidos C, et al. (2020) Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun;87:172–6. 10.1016/j.bbi.2020.05.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ozdin S, Bayrak Ozdin S (2020) Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry:20764020927051 10.1177/0020764020927051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mazza C, Ricci E, Biondi S, Colasanti M, Ferracuti S, Napoli C, et al. (2020) A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors. Int J Environ Res Public Health;17(9). 10.3390/ijerph17093165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fuhr DC, Acarturk C, McGrath M, Ilkkursun Z, Sondorp E, Sijbrandij M, et al. (2019) Treatment gap and mental health service use among Syrian refugees in Sultanbeyli, Istanbul: a cross-sectional survey. Epidemiol Psychiatr Sci;29:e70 10.1017/S2045796019000660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Tekeli-Yesil S, Isik E, Unal Y, Aljomaa Almossa F, Konsuk Unlu H, Aker AT (2018) Determinants of Mental Disorders in Syrian Refugees in Turkey Versus Internally Displaced Persons in Syria. Am J Public Health;108(7):938–45. 10.2105/AJPH.2018.304405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Acarturk C, Cetinkaya M, Senay I, Gulen B, Aker T, Hinton D (2018) Prevalence and Predictors of Posttraumatic Stress and Depression Symptoms Among Syrian Refugees in a Refugee Camp. J Nerv Ment Dis;206(1):40–5. 10.1097/NMD.0000000000000693 [DOI] [PubMed] [Google Scholar]
  • 31.Bhopal RS (2020) COVID-19: Immense necessity and challenges in meeting the needs of minorities, especially asylum seekers and undocumented migrants. Public Health;182:161–2. 10.1016/j.puhe.2020.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Brandenberger J, Baauw A, Kruse A, Ritz N (2020) The global COVID-19 response must include refugees and migrants. Swiss Med Wkly;150:w20263 10.4414/smw.2020.20263 [DOI] [PubMed] [Google Scholar]
  • 33.Junior JG, de Sales JP, Moreira MM, Pinheiro WR, Lima CKT, Neto MLR (2020) A crisis within the crisis: The mental health situation of refugees in the world during the 2019 coronavirus (2019-nCoV) outbreak. Psychiatry Res;288:113000 10.1016/j.psychres.2020.113000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.UN Refugee Agency steps up COVID-19 preparedness, prevention and response measures [cited 28.06.2020]. Available from: https://www.unhcr.org/uk/news/press/2020/3/5e677f634/un-refugee-agency-steps-covid-19-preparedness-prevention-response-measures.html.
  • 35.Murvet Yilmaz NA, Canan Dogan, Filiz Turan, Emine Yilmaz, Yesim Vardar, Emine Balci, et al. (2019) Comparison of the Socio-Economic Situation and Living Conditions of Syrian and Underprivileged Turkish Patients Receiving Hemodialysis. Turkish Journal of nephrology;28(4):269–74. [Google Scholar]

Decision Letter 0

Jose A Muñoz-Moreno

25 Nov 2020

PONE-D-20-26043

Effect of COvid-19 on mental health in Syrian and Turkish maintenance HemoDialysis patients: COST-HD study

PLOS ONE

Dear Dr. Sakaci,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We apologize for the delay in our response. We have had some difficulties with the reviewers of this work and that is the reason why I have reviewed the work mainly on my own. You will find my comments below.

Please submit your revised manuscript by Jan 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Jose A. Muñoz-Moreno, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.) Please amend your current ethics statement to address the following concerns: Please explain why written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure.

3) In your ethics statement in the Methods section and in the online submission form, please provide additional information about the retrospective demographic data used in your study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

4.) Please include the date(s) on which you accessed the databases or records to obtain the retrospective demographic data used in your study.

5.) We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Comments to Authors

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: - The tittle should not mention "mental health", since the study is only investigating depressive symptoms and many other dimensions of mental health are not addressed.

- I would also recommend including in the tittle "refugees", since this is a key point of the study.

- It is mentioned that pneumonia of unknown cause was detected on 31 December 2019, but it was reported on December 30th: https://promedmail.org/promed-post/?id=6864153

- Importantly, all the manuscript refers to "depression". But this work did not investigate depression rigorously, but a screening of depressive symptoms. Depression should be thoroughly diagnosed by a clinical interview, or alternatively, in the case of research setting, with more complete methodology. BDI is merely a method to measure depressive symptoms, with relevant limitations in fact. Authors should be really cautious on this point.

- In Abstract, it is reported that demographic and clinical data were collected from patients' files; what type of files? This feature should be clarified. Adapt also in the manuscript (Methods).

- Which version of BDI was used? An appropriate reference should be cited the first time it is mentioned in text.

- In Abstract, when BDI means are reported, the numbers in parenthesis are not defined.

- In Abstract, the last sentence in Results should clarify whether those factors were found in the total sample or only in one of the groups.

- In Abstract, Conclusions, it is stated that HD patients were affected by the pandemic, but this work did not investigate any aspect about impact of COVID-19 specifically. The study was cross-sectional, with no prospective data, therefore authors were not allowed to conclude any information on the affectation by the pandemic. If there is any reference of some work previously published in that regard, it could be provided.

- Introduction, line 73, it is stated that depression can be diagnosed by questionnaires. Again, depression should be carefully diagnosed with the help of questionaries, alongside a proper psychiatric interview. In fact, the citation provided in the text is referring to screening for depression very clearly.

- Introduction, line 75, "Syrian civil" is missing a word.

- In the Introduction, allusions to impact of the pandemic are made, but, again, the study essentially offers a picture of the depressive symptoms.

- Methods, line 82, the date should be adapted to English format. Importantly, all dates provided in the Abstract and manuscript should be adapted as well.

- Methods, line 96, "was accepted as suspicion of depression".

- Results, line 121, "due to following".

- Results, line 122, "COVID-19".

- Results, line 131, sentence should be rephrased.

- Results, line 133, "depression" should be changed to "depressive symptoms." Also in in the Abstract and all along the manuscript.

- 50.7% of the Turkish cohort were women, 18.2% in the Syrian cohort (p=0.014). And depressive symptoms were more prevalent in the Syrian population (p=0.03). However, when BDI outcomes were stratified according to a score of 14, the proportion of female patients did not differ. This result should be confirmed.

- In Results, firstly, a description of the cohorts is offered; later, both groups are joined to study the factors related to the existence of suspicion of depression (BDI score of 14); and finally, again, groups are separated to offer the difference in BDI means according to groups. The third part should be provided after the first one, and factors related to suspicion of depression should be the last one. In fact, that is the order followed in the Abstract.

- Discussion, line 153, "male, although."

- Discussion, line 153, 54% is with no decimal, and 51.6% include it.

- The paragraph concerning the description of BDI and its potential usefulness is really scarce. Other advantages should be added, and, importantly, its main limitations; for example, that it is widely biased by organic symptoms, or that the original BDI version has been updated by BDI-II years ago.

- Outcomes on BDI could be presented as 2 subscales (cognitive-affective and somatic-performance). Because only one questionnaire has been applied in the study, incorporating this information to the manuscript could definitively offer more strength to the work.

- Proportion of women was significantly higher in the Syrian group compared to the Turkish group. Depressive symptoms were also higher in the same group. This could be perfectly attributed then to commonly higher rates of depressive status in the general population, or in refugee women as well. This point should be properly justified and argued in Discussion.

- In Discussion, alongside the general recommendation to provide mental support to Syrian refugees, other specific suggestions could be made. In my opinion, this part of the Discussion is truly important, since authors should use their knowledge and experience to state clearly specific interventions that could be delivered and implemented.

- Table 1: Kt/V mean for all patients, there is a mistake in the decimal.

- Table 1: one decimal, two, or three for data shown? This is also important for the Abstract and along the manuscript.

- Figure 1: format mistakes should be corrected.

- Figure 1, title: "Details of the patient cohort."

- Figure 2: p value could be included in the graph.

- Finally, and very importantly, English grammar and style should be revised for all the text.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jan 4;16(1):e0244347. doi: 10.1371/journal.pone.0244347.r002

Author response to Decision Letter 0


8 Dec 2020

Response to reviewers

Dear reviewer,

Thank you very much for your review and contributions.

Your contributions and our answers can be seen below.

Kind regards

Tamer Sakaci

Journal requirements

1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Answer:

Title page and manuscript have been updated regarding Journal’s rules.

2.) Please amend your current ethics statement to address the following concerns: Please explain why written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure.

Answer:

We are sorry for forgetting to add this detail to the manuscript. All participants had given written consent when they had filled the BDI form. This detail has been added to the first paragraph of method section (lines 67-69 at manuscript file) as “Participants signed written consent forms both to participate in the study and to have data from their medical records used in research.”

3) In your ethics statement in the Methods section and in the online submission form, please provide additional information about the retrospective demographic data used in your study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Answer:

We are sorry for skipping to add these details. Data were anonymized before our access. Consent form was containing details to have data from patients’ medical records. The sentence regarding these items has been added to the first paragraph of methods section (line 67 at manuscript file) as follows: “All data were fully anonymized before access. Participants signed written consent forms both to participate in the study and to have data from their medical records used in research. “

4.) Please include the date(s) on which you accessed the databases or records to obtain the retrospective demographic data used in your study.

Answer

The data was accessed at the time of BDI questionnaire. It has been added to the end of second paragraph of methods section (lines 75,76 at manuscript file) as “Past medical records were accessed at the same day patients completed the BDI questionnaire.”

5.) We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Answer:

We have uploaded our date via Dryad system by doi:10.5061/dryad.wwpzgmshv. The data will be open upon acceptance of the article. The link to access data is https://datadryad.org/stash/share/unPym5dTZ-c9G-A1p6cbGxD_OEsTUTdPlzYhJQXbO5M

Comments to Authors

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: - The tittle should not mention "mental health", since the study is only investigating depressive symptoms and many other dimensions of mental health are not addressed.

Answer:

The title is updated as “Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic”

- I would also recommend including in the tittle "refugees", since this is a key point of the study.

Answer:

The title is updated as “Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic”

- It is mentioned that pneumonia of unknown cause was detected on 31 December 2019, but it was reported on December 30th: https://promedmail.org/promed-post/?id=6864153

Answer:

We are sorry this mistake. It was corrected as 30 December 2019 at abstract and introduction section.

- Importantly, all the manuscript refers to "depression". But this work did not investigate depression rigorously, but a screening of depressive symptoms. Depression should be thoroughly diagnosed by a clinical interview, or alternatively, in the case of research setting, with more complete methodology. BDI is merely a method to measure depressive symptoms, with relevant limitations in fact. Authors should be really cautious on this point.

Answer:

Thank you for this advice. The abstract and manuscript is changed regarding your suggestion. Depressive symptoms and suspicion of depression are the terms used instead of depression.

- In Abstract, it is reported that demographic and clinical data were collected from patients' files; what type of files? This feature should be clarified. Adapt also in the manuscript (Methods).

Answer:

Details of these files have been added to abstract (lines 25-27 at manuscript file) as follows: “Demographic and clinical data were collected retrospectively from patients’ files containing details about past medical history, demographic variables and laboratory values.”

Definitions and details of the files has been added to the methods section (lines 77-79 at manuscript file) as well: “Demographic data were collected retrospectively from patients’ files. These files contain the demographic details of patients filled at admission to our dialysis center and patients’ past and current laboratory values.”

- Which version of BDI was used? An appropriate reference should be cited the first time it is mentioned in text.

Answer:

The original version of BDI published at 1961 was used. It is referred as well (reference number 11). The text has been updated (lines 88,89 at manuscript file) as follows: “The validated Turkish and Arabic forms of BDI version I were filled by patients themselves [9-11].”

- In Abstract, when BDI means are reported, the numbers in parenthesis are not defined.

Answer:

We are sorry for mistake. Abstract has been updated (lines 32, 33 at manuscript file) as “The median BDI (interquartile range) score for Turkish and Syrian patients were 12 (7-23) and 19.5 (12.7-25.2), respectively (p=0.03).”

- In Abstract, the last sentence in Results should clarify whether those factors were found in the total sample or only in one of the groups.

Answer:

It was found in the total sample. This sentence (lines 35-37 at manuscript file) has been changed as “Regarding all patients, phosphorus level, Kt/V, and nationality were significantly different between patients with and without depression (p=0.023, 0.039, 0.013, respectively).”

- In Abstract, Conclusions, it is stated that HD patients were affected by the pandemic, but this work did not investigate any aspect about impact of COVID-19 specifically. The study was cross-sectional, with no prospective data, therefore authors were not allowed to conclude any information on the affectation by the pandemic. If there is any reference of some work previously published in that regard, it could be provided.

Answer:

Thank you for this missing point. We agree you. The first part of the first sentence of conclusion section has been deleted (lines 38-40 at manuscript file) as follows: “Syrian patients had higher BDI scores and more depressive symptoms than Turkish patients. Additional national measures for better integration and more mental support to Syrian HD patients are needed. ”

- Introduction, line 73, it is stated that depression can be diagnosed by questionnaires. Again, depression should be carefully diagnosed with the help of questionaries, alongside a proper psychiatric interview. In fact, the citation provided in the text is referring to screening for depression very clearly.

Answer:

Thank you very much for this caution. We agree you. The sentence (lines 55, 56 at manuscript file) changed as “It can be screened by a few types of self-questionnaires validated in this population such as Beck depression inventory (BDI)”.

- Introduction, line 75, "Syrian civil" is missing a word.

Answer:

It has been completed (line 58 at manuscript file) as “Syrian civil war has been started on 11 March 2011.”

- In the Introduction, allusions to impact of the pandemic are made, but, again, the study essentially offers a picture of the depressive symptoms.

Answer:

The make this effect less, the sentence at the introduction section “We do not know if pandemic affected Syrian patients’ mental health different than Turkish ones” has been changed (lines 60-62 at manuscript file) as “We do not know if there is a difference in depressive symptom frequency between Syrian refugee HD patients and Turkish ones or not”.

- Methods, line 82, the date should be adapted to English format. Importantly, all dates provided in the Abstract and manuscript should be adapted as well.

Answer:

We agree you. That date and the others are all adapted.

- Methods, line 96, "was accepted as suspicion of depression".

Answer:

We agree you. The sentence (line 87 at manuscript file) is corrected as your suggestion.

- Results, line 121, "due to following".

Answer:

We are sorry for that. It has been corrected.

- Results, line 122, "COVID-19".

Answer:

We are sorry for that. It has been corrected.

- Results, line 131, sentence should be rephrased.

Answer:

It has been rephrased (line 127 at manuscript file) as “Marriage rate was 49.3% in Turkish and 81.8% in Syrian patients”.

- Results, line 133, "depression" should be changed to "depressive symptoms." Also in in the Abstract and all along the manuscript.

Answer:

All text is updated regarding your advice. Thank you for this recommendation.

- 50.7% of the Turkish cohort were women, 18.2% in the Syrian cohort (p=0.014). And depressive symptoms were more prevalent in the Syrian population (p=0.03). However, when BDI outcomes were stratified according to a score of 14, the proportion of female patients did not differ. This result should be confirmed.

Answer:

The tests and results are confirmed again. The results seem correct. The confusing fact might be that the when BDI scores were stratified, nationalities were not taken into account. Grouping variable in this comparison is BDI stratification, not nationality.

More analysis has been done to make it clear as follows:

Frequency of depressive symptoms in Syrian female patients was similar to Turkish female patients (p=0.05). It might be due to limited number of participants because p value is close to the significance level. It was significantly different between nationalities in male patients (p=0.034).

- In Results, firstly, a description of the cohorts is offered; later, both groups are joined to study the factors related to the existence of suspicion of depression (BDI score of 14); and finally, again, groups are separated to offer the difference in BDI means according to groups. The third part should be provided after the first one, and factors related to suspicion of depression should be the last one. In fact, that is the order followed in the Abstract.

Answer:

The flow of results has been changed regarding your recommendation.

- Discussion, line 153, "male, although."

Answer:

It is corrected. Thank you.

- Discussion, line 153, 54% is with no decimal, and 51.6% include it.

Answer:

The sentence (lines 156-158 at manuscript file) has been changed as “In our cohort, most of the Syrian patients (81.8%) were male, although 54.0% of all Syrian refugees [14] and 51.6 % of Syrian hemodialysis patients [5] in Turkey were male.”

- The paragraph concerning the description of BDI and its potential usefulness is really scarce. Other advantages should be added, and, importantly, its main limitations; for example, that it is widely biased by organic symptoms, or that the original BDI version has been updated by BDI-II years ago.

Answer:

Thank you for this contribution. The paragraph (lines 159-170 a manuscript file) has been updated as follows:

“Screening frequency of depressive symptoms by the BDI score without a clinical interview is an established strategy in ESRD patients [3, 7, 8]. BDI-I questionnaire was used in this study because of some advantages. It was a practical, easy, reliable and valid self-report system that has been used since 1961 [11, 15]. It could be completed by patients themselves which would minimize close and long contacts with patients during the pandemic and prevent potential COVID-19 transmission. Moreover, to the best of our knowledge, it is the only self-report screening measure that has been validated in both Turkish and Arabic languages. Besides these advantages, BDI-I form has some limitations. It has been focused more on cognitive and affective symptoms than somatic functions. Furthermore, it could be biased by organic symptoms. It was updated as BDI-II form at 1996 in response to American Psychiatric Association’s publication of DSM-IV criteria for major depressive disorder [16]. Despite this updated version, BDI-I is still widely used in different patient populations [17]. “

- Outcomes on BDI could be presented as 2 subscales (cognitive-affective and somatic-performance). Because only one questionnaire has been applied in the study, incorporating this information to the manuscript could definitively offer more strength to the work.

Answer:

We added data regarding BDI subscales to the relevant sections as follows:

Method section:

These two sentences (lines 97, 98 at manuscript file) were added at the end of methods section: “BDI score was also divided into cognitive-affective and somatic-performance subscales [12]. These were compared to nationality as well.”

Results section:

The new findings are added (lines 129-132 at manuscript file) as follows: The median somatic-performance subscale scores for Turkish and Syrian patients were 2 (1-5) and 3.5 (2-6.2), respectively (p=0.02). Affective-cognitive subscale median score for Turkish patients was 9 (6-18) whereas it was 14 (10-18) for Syrian patients (p=0.05).

Discussion section:

Some additions and rephrasing were done as follows (lines 194-198 at manuscript file): “However, providing equal physical and financial conditions only at peridialysis environment seemed to be insufficient for equal score expectation because we found that total BDI score, somatic-performance subscale score and affective-cognitive subscale score were all higher in Syrian patients than Turkish ones. As a result, it seems that we need to provide many other facilities to talk about equality between the two groups.”

- Proportion of women was significantly higher in the Syrian group compared to the Turkish group. Depressive symptoms were also higher in the same group. This could be perfectly attributed then to commonly higher rates of depressive status in the general population, or in refugee women as well. This point should be properly justified and argued in Discussion.

Thank you for this comment.

The Syrian female patients was 18.2% of their cohort (n=4) and the Turkish female patients was 52% of their cohort (n=39).

Regarding all patients, depressive symptom frequency was similar between gender (p=0.482). Regarding only females, all Syrian females and 48.7% of Turkish females had depressive symptoms (p=0.05). statistical significance may not be reached due to limited number of patients. Regarding only Syrian patients, median BDI score for males was 17 (11.7-23.5). It was 23.5 (19.5-30.5) (p=0.141). Comparison of gender in Syrian patients against BDI score ≤14 or >14 was not significant (p=0.176). As a result, even though all Syrian females had depressive symptoms, its frequency was similar to Syrian males.

- In Discussion, alongside the general recommendation to provide mental support to Syrian refugees, other specific suggestions could be made. In my opinion, this part of the Discussion is truly important, since authors should use their knowledge and experience to state clearly specific interventions that could be delivered and implemented.

Answer:

Thank you for this contribution. The related paragraph (lines 189-205 at manuscript file) is changed as follows:

“Yilmaz et al have shown that Syrian maintenance HD patients were less compliant with their HD schedules [35]. Their per capita income was lower than Turkish patients, although their employment rate was higher. The number of Syrian household members was higher than Turkish patients but hot water accessibility was lower for the Syrian group. Similar BDI scores might be expected between Turkish and Syrian patients if the conditions were the same for both groups. However, providing equal physical and financial conditions only at peridialysis environment seemed to be insufficient for equal score expectation because we found that total BDI score, somatic-performance subscale score and affective-cognitive subscale score were all higher in Syrian patients than Turkish ones. As a result, it seems that we need to provide many other facilities to talk about equality between the two groups. These might be steps to improve language barrier between adult Syrian patients and Turkish service providers at all facilities including hospitals and other institutions. This could be with two methods: enabling Syrians to learn Turkish and maintaining more translation support at every institution or integrating native Syrian employees to these institutions like hospitals. Language support would help integration with the Turkish population. Most importantly, they should have been accepted and behaved like as others in Turkey, not as refugees. Integrating 4 million people into an economically hard stressed country in the midst of a pandemic is not easy but it seems as a necessity “.

- Table 1: Kt/V mean for all patients, there is a mistake in the decimal.

Answer:

I am sorry for this. It is corrected as “1.7±.0.2”.

- Table 1: one decimal, two, or three for data shown? This is also important for the Abstract and along the manuscript.

Answer:

Abstract, all parts of the manuscript, tables are updated as one decimal format.

- Figure 1: format mistakes should be corrected.

Answer:

They are corrected.

- Figure 1, title: "Details of the patient cohort."

Answer:

It is corrected.

- Figure 2: p value could be included in the graph.

Answer:

It is added.

- Finally, and very importantly, English grammar and style should be revised for all the text.

Answer:

Thank you for this comment. It has been rechecked by us and a native speaker, Jonathan Ling. Jonathan has reviewed the manuscript and revised it regarding your suggestions. Due to these reasons, the authors of this manuscript think that he deserves to be an author is this article. Could you please add Jonathan Ling as a co-author of this article? ________________________________________

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Jose A Muñoz-Moreno

9 Dec 2020

Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic

PONE-D-20-26043R1

Dear Dr. Sakaci,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jose A. Muñoz-Moreno, Ph.D.

Academic Editor

PLOS ONE

Acceptance letter

Jose A Muñoz-Moreno

11 Dec 2020

PONE-D-20-26043R1

Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic

Dear Dr. Sakaci:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jose A. Muñoz-Moreno

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    We have uploaded our date via Dryad system by doi:10.5061/dryad.wwpzgmshv.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES